| ‘Mast cells and platelets are not covered in this review. For informa CF Nathan Biological Response Mediators and Modulators, 221, 1983 | | 1983 |
| 1366 Supression of atherogenesis in cholesterol-fed treated with nifedipine. Philip D. Henry and Karen Bentley 1370 Deficiency of protein C in congenital throm disease. John H … B DeMark, C McKinley, R Showalter, W Erfling, DZ Braverman, ... | | |
| 2017 Association of American Physicians George M. Kober Medal Introduction of Laurie H. Glimcher, MD CF Nathan The Journal of clinical investigation 127 (10), 3575-3575, 2017 | | 2017 |
| A commentary: inducible nitric oxide synthase C Nathan Research in immunology 142 (7), 600-602, 1991 | 9 | 1991 |
| A glutamate‐alanine‐leucine (EAL) domain protein of Salmonella controls bacterial survival in mice, antioxidant defence and killing of macrophages: role of cyclic … KB Hisert, M MacCoss, MU Shiloh, KH Darwin, S Singh, RA Jones, S Ehrt, ... Molecular microbiology 56 (5), 1234-1245, 2005 | 161 | 2005 |
| A journey in science: promise, purpose, privilege C Nathan Molecular Medicine 19 (1), 305, 2013 | 2 | 2013 |
| A membrane protein preserves intrabacterial pH in intraphagosomal Mycobacterium tuberculosis OH Vandal, LM Pierini, D Schnappinger, CF Nathan, S Ehrt Nature medicine 14 (8), 849, 2008 | 275 | 2008 |
| A multi-stress model for high throughput screening against non-replicating Mycobacterium tuberculosis B Gold, T Warrier, C Nathan Mycobacteria protocols, 293-315, 2015 | 24 | 2015 |
| A novel antioxidant gene from Mycobacterium tuberculosis S Ehrt, MU Shiloh, J Ruan, M Choi, S Gunzburg, C Nathan, Q Xie, ... Journal of Experimental Medicine 186 (11), 1885-1896, 1997 | 136 | 1997 |
| A novel antioxidant gene from Mycobacterium tuberculosis (vol 186, pg 1885, 1997) S Ehrt, MU Shiloh, J Ruan, M Choi, S Gunzburg, C Nathan, QW Xie, ... JOURNAL OF EXPERIMENTAL MEDICINE 187 (1), 141-141, 1998 | | 1998 |
| A novel synthetic oleanane triterpenoid, 2-cyano-3, 12-dioxoolean-1, 9-dien-28-oic acid, with potent differentiating, antiproliferative, and anti-inflammatory activity N Suh, Y Wang, T Honda, GW Gribble, E Dmitrovsky, WF Hickey, ... Cancer Research 59 (2), 336-341, 1999 | 344 | 1999 |
| A philosophy of anti-infectives as a guide in the search for new drugs for tuberculosis C Nathan, B Gold, G Lin, M Stegman, LPS de Carvalho, O Vandal, ... Tuberculosis 88, S25-S33, 2008 | 61 | 2008 |
| A protecting group-free synthesis of deazathiamine: A step toward inhibitor design H Zhao, LPS de Carvalho, C Nathan, O Ouerfelli Bioorganic & medicinal chemistry letters 20 (22), 6472-6474, 2010 | 9 | 2010 |
| A semi-automated micro-assay for H2O2 release by human blood monocytes and mouse peritoneal macrophages J De la Harpe, CF Nathan Journal of immunological methods 78 (2), 323-336, 1985 | 177 | 1985 |
| A simple method for counting adherent cells: application to cultured human monocytes, macrophages and multinucleated giant cells A Nakagawara, CF Nathan Journal of immunological methods 56 (2), 261-268, 1983 | 192 | 1983 |
| A time of change CF Nathan, MC Nussenzweig, T Pulvirenti Journal of Experimental Medicine 214 (1), 1-2, 2017 | 1 | 2017 |
| Abrupt Expression of TLR4 in Z Xiang, A Ding, EF Cohn, C Nathan, D Radzioch, H Yu J Immunol 176, 1185-1194, 2006 | | 2006 |
| Abrupt expression of TLR4 in TLR4-deficient macrophages imposes a selective disadvantage: genetic evidence for TLR4-dependent responses to endogenous, nonmicrobial stimuli EF Cohn, C Nathan, D Radzioch, H Yu, Z Xiang, A Ding The Journal of Immunology 176 (2), 1185-1194, 2006 | 4 | 2006 |
| Acid resistance in Mycobacterium tuberculosis OH Vandal, CF Nathan, S Ehrt Journal of bacteriology 191 (15), 4714-4721, 2009 | 190 | 2009 |
| Acid-susceptible mutants of Mycobacterium tuberculosis share hypersusceptibility to cell wall and oxidative stress and to the host environment OH Vandal, JA Roberts, T Odaira, D Schnappinger, CF Nathan, S Ehrt Journal of bacteriology 191 (2), 625-631, 2009 | 142 | 2009 |
